- Home
- ACIU vs FRAF Comparison
ACIU vs FRAF Comparison
Compare ACIU & FRAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- FRAF
- Stock Information
- Founded
- ACIU 2003
- FRAF 1906
- Country
- ACIU Switzerland
- FRAF United States
- Employees
- ACIU N/A
- FRAF N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- FRAF Major Banks
- Sector
- ACIU Health Care
- FRAF Finance
- Exchange
- ACIU Nasdaq
- FRAF Nasdaq
- Market Cap
- ACIU 213.3M
- FRAF 190.9M
- IPO Year
- ACIU 2016
- FRAF N/A
- Fundamental
- Price
- ACIU $2.04
- FRAF $46.70
- Analyst Decision
- ACIU Strong Buy
- FRAF
- Analyst Count
- ACIU 1
- FRAF 0
- Target Price
- ACIU $12.00
- FRAF N/A
- AVG Volume (30 Days)
- ACIU 109.7K
- FRAF 18.2K
- Earning Date
- ACIU 08-05-2025
- FRAF 10-21-2025
- Dividend Yield
- ACIU N/A
- FRAF 2.82%
- EPS Growth
- ACIU N/A
- FRAF 5.82
- EPS
- ACIU N/A
- FRAF 3.29
- Revenue
- ACIU $36,362,036.00
- FRAF $74,998,000.00
- Revenue This Year
- ACIU N/A
- FRAF N/A
- Revenue Next Year
- ACIU $1,022.98
- FRAF N/A
- P/E Ratio
- ACIU N/A
- FRAF $14.19
- Revenue Growth
- ACIU 86.71
- FRAF 8.15
- 52 Week Low
- ACIU $1.43
- FRAF $28.01
- 52 Week High
- ACIU $3.98
- FRAF $48.24
- Technical
- Relative Strength Index (RSI)
- ACIU 44.83
- FRAF 78.02
- Support Level
- ACIU $2.05
- FRAF $46.34
- Resistance Level
- ACIU $2.19
- FRAF $48.24
- Average True Range (ATR)
- ACIU 0.11
- FRAF 0.91
- MACD
- ACIU -0.01
- FRAF 0.40
- Stochastic Oscillator
- ACIU 4.55
- FRAF 80.73
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About FRAF Franklin Financial Services Corporation
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.